These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 570847)

  • 1. Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity.
    Russell NH; Keenan JP; Bellingham AJ
    Br J Haematol; 1979 Mar; 41(3):417-25. PubMed ID: 570847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of thromboxane A2 in platelet aggregation. Preliminary report].
    Mashimo N; Yamaguchi S; Watanabe Y; Mitani J; Sakurada H; Numano F
    Rinsho Byori; 1979; Suppl 40():122-9. PubMed ID: 551220
    [No Abstract]   [Full Text] [Related]  

  • 3. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subnormal platelet response to thromboxane A2 in a patient with chronic myeloid leukaemia.
    Okuma M; Takayama H; Uchino H
    Br J Haematol; 1982 Jul; 51(3):469-77. PubMed ID: 6809032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency.
    Horellou MH; Lecompte T; Lecrubier C; Fouque F; Chignard M; Conard J; Vargaftig BB; Dray F; Samama M
    Am J Hematol; 1983 Feb; 14(1):1-9. PubMed ID: 6404162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
    Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
    Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV; Ayer DE; Gorman RR
    Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
    Lages B; Malmsten C; Weiss HJ; Samuelsson B
    Blood; 1981 Mar; 57(3):545-52. PubMed ID: 7459434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
    Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet thromboxane production during endotoxin shock.
    Prancan A; Simon D; Pope L
    Agents Actions; 1981 Dec; 11(6-7):648-50. PubMed ID: 7340458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
    Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K
    Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired function of TXA2 and/or calcium in the platelets from SHRSP at hypertensive ages.
    Tomita T; Umegaki K; Nakamura K; Hayashi E
    Thromb Res; 1984 Jul; 35(2):219-30. PubMed ID: 6474418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.